Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369285
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-04-12
Brief Title:
A Study of Alisertib in Combination with Endocrine Therapy in Patients with HR-positive HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology Inc
Organization:
Puma Biotechnology Inc
Organization Data
Organization:
Puma Biotechnology Inc
Class:
INDUSTRY
Study ID:
PUMA-ALI-1201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Puma Biotechnology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None